Clinical Trial

Microbiological Characterization and Antibiotic Resistance Profiling of Providencia Spp,: An Emerging Pathogen Isolated From Urinary Tract Infections

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Aims of the Research: 1. Isolation and identification of Providencia spp. from UTIs. 2. Genotypic confirmation of Providencia isolates. 3. Determination of antimicrobial sensitivity patterns of isolated Providencia spp. 4. Characterization of some virulence factors of Providencia spp. 5. Molecular characterization of multidrug-resistance gene antibiotics. 6. Determination of risk factors for Providencia UTIs.
Trial Details
NCT Number NCT07204769
Lead Sponsor Assiut University
Conditions Urinary Tract Infection
Enrollment 241 participants
Start Date 2026-05-01
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-10-02